Medical device and MedTech insights, news, tips and more

Nanox Signs Agreement With The Gateway Group for the Deployment of 1,000 Nanox.ARC Units Across Australia, New Zealand, and Norway 

March 2, 2020


NANO-X IMAGING LTD ( (“Nanox” or the “Company”), an innovative medical imaging technology company, announces it has secured an exclusive distribution deal with The Gateway Group (“Gateway”), one of Australia’s largest independent product distributors including health, wellness, medical supplies and devices.


The agreement has an initial term of three years and is renewable for an additional term of three years with both parties’ mutual consent. Subject to receiving local regulatory approvals, the parties will collaborate on the deployment and operation of 1,000 Nanox Systems comprised of the Nanox.ARC and the Nanox.CLOUD. The parties aim to provide medical imaging services across Australia, New Zealand and Norway at affordable prices for communities of varying socio-economic status.

The Nanox System will offer a range of medical imaging services, from 2D X-ray to 3D Tomosynthesis computed tomography. Nanox will provide the systems to Gateway once approved by the local regulatory authorities for deployment in areas that have little to no medical imaging facilities, as well as in major cities. The services are planned to be operated on a pay-per-scan business model and include online radiology diagnostics and medical AI decision assistive algorithms implementation. Nanox and Gateway’s joint initiative will target unit deployment in clinics and medical centers and Nanox will provide staff training and local support.

According to the agreement, Gateway agrees to guarantee a minimum service fee of $58 million per year for three years to Nanox.

“We plan to reach even the most remote locations on the globe with advanced medical imaging services,” says Ran Poliakine, Founder and Chief Executive Officer of Nanox. “The agreement with Gateway is the direct implementation of this strategy. We want medical imaging to be available in rural areas as well as major cities alike, and we look forward to working with the team at Gateway to help us realize this social agenda.”

Gateway provides a wide range of products to over 20,000 locations with representation of medical device companies such as BrainsWay, Dex and others. The transaction was formed with the help of the Southern Israel Bridging Fund (SIBF) who operate to identify and connect between Israeli and global companies for mutual business opportunities (

“Nanox has a unique business model that is designed to improve accessibility and affordability of early-detection services worldwide,” says Ricky Neumann, CEO of Gateway. “People in some countries who live in rural areas need to drive hours to get to a medical imaging facility and wait for months to get diagnostics results. We intend to change that with Nanox.”

See Full Press Release: Nanox Signs Agreement With The Gateway Group for the Deployment of 1,000 Nanox.ARC Units Across Australia, New Zealand, and Norway | Business Wire


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.